Next-generation cell storage and cryopreservation solutions

As experts in cellular protection, Targa is developing preservation solutions to maintain cell viability and function across ambient, controlled-temperature, and cryopreservation workflows for cell therapy and biomanufacturing.

The challenge

From manufacturing to patient — where living cells are most vulnerable

The quality of a living cell product at the time of manufacture is not the quality that reaches the patient.

Living cell products can lose viability and function during storage, transport, freezing, thawing and handling. These losses can reduce consistency, yield and therapeutic performance before the product reaches the patient.

For living cell therapies, including CAR-T cells, immune cells, stem and progenitor cells, and regenerative or structural cell populations, these losses can directly impact therapeutic performance and patient outcomes.

Storage and transport stress

Temperature shifts and extended handling can compromise membrane integrity, viability and recovery.

The cryopreservation burden

Freezing, thawing and cryoprotectant exposure can reduce cell recovery and may introduce toxicity concerns or added processing steps before use.

Loss of biological function

Production-related, mechanical, and environmental stress can impair cell potency, consistency, and functional integrity.

From cell storage to organ rescue — the same science, applied differently

Our products

Preservation at a cellular level

Advanced Cryopreservation Solution

A cryopreservation medium designed to replace DMSO-based formulations with a safer, clinically compatible alternative — preserving high-value cell products through freezing and thawing while enabling simpler, directly infusible downstream use.

  • Reduces reliance on DMSO-based formulations

  • Supports simplified post-thaw processing

  • Maintains cell viability, recovery, and function post-thaw

  • Designed to support cryopreservation workflows across stem cell and broader cell therapy applications
Ambient and Controlled-Temperature Cell Storage

Short-term cell preservation from 4°C to room temperature, designed to maintain cell morphology, viability and biological function during the critical window between manufacturing and clinical use.

  • Supports post-storage viability and cell recovery

  • Flexible temperature range: 4°C to room temperature

  • Animal component-free, serum-free, protein-free formulation
  • Reduces cold-chain complexity in biomanufacturing logistics and transport
Applications

Built for clinical workflows where cell quality matters most

Cell therapy development

Designed for workflows where living cells must maintain viability and function during handling, storage and transport.

Immune cell workflows

Relevant to immune cell manufacturing and processing workflows where recovery and function are critical.

Biomanufacturing

Designed to support consistency, recovery and workflow flexibility across cell-processing operations.

Stem and progenitor cell banking

Potential application for high-value stem and progenitor cells requiring reliable storage and recovery.

Regenerative medicine

Potential use in regenerative and tissue-repair cell applications requiring preservation of cell integrity.

Research and development

Supports exploratory workflows that require reliable cell preservation under variable storage conditions.

Work with us

Preserving cell quality across workflows

For cell therapy
manufacturers

Advanced Solutions for Cell Storage and Cryopreservation

Targa is developing advanced cell-storage and cryopreservation solutions designed to preserve cell viability and function across ambient, controlled-temperature, and cryopreservation workflows.

For research &
academic institutions

Preserve cell quality from bench to bedside

Targa welcomes research collaborations to evaluate cell-preservation technologies across relevant cell types, storage conditions and translational workflows.

Targa is partnering with preservation and perfusion technology companies—platforms, devices, and solutions. If our technology could enhance your organ-recovery offering, let’s connect.

Targa is partnering with preservation and perfusion technology companies—platforms, devices, and solutions. If our technology could enhance your organ-recovery offering, let’s connect.